Financhill
Sell
40

PZG Quote, Financials, Valuation and Earnings

Last price:
$0.38
Seasonality move :
5.14%
Day range:
$0.37 - $0.39
52-week range:
$0.31 - $0.69
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.72x
Volume:
527.2K
Avg. volume:
199.5K
1-year change:
-2.36%
Market cap:
$25.6M
Revenue:
--
EPS (TTM):
-$0.12

Earnings Data

Next earnings date for PZG
--
Most recent earnings per share
-$0.03
Missed by --
(Dec 31/2024)
Consensus Estimate
-$0.03
(Dec 31/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PZG Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 -- -- -- -$0.02 --
12/31/2024 Q4 -- -- -$0.03 -$0.03 --
09/30/2024 Q3 -- -- -$0.02 -$0.02 --
06/30/2024 Q2 -- -- -$0.04 -$0.03 -$0.01
03/31/2024 Q1 -- -- -$0.03 -$0.03 --
12/31/2023 Q4 -- -- -$0.03 -$0.02 -$0.01
09/30/2023 Q3 -- -- -$0.04 -$0.02 -$0.02
06/30/2023 Q2 -- -- -$0.03 -- --
05/10/2023 Q1 -- -- -$0.03 -- --
02/03/2023 Q4 -- -- -$0.03 -$0.02 -$0.01
11/09/2022 Q3 -- -- -$0.04 -$0.02 -$0.02
06/30/2022 Q2 -- -- -$0.04 -$0.03 -$0.01
05/10/2022 Q1 -- -- -$0.03 -$0.04 $0.01
02/04/2022 Q4 -- -- -$0.07 -$0.04 -$0.03
11/09/2021 Q3 -- -- -$0.05 -$0.03 -$0.02
09/24/2021 Q2 -- -- -$0.04 -$0.04 --
05/07/2021 Q1 -- -- -$0.04 -$0.04 --
02/05/2021 Q4 -- -- $0.05 -$0.04 $0.09
11/05/2020 Q3 -- -- -$0.04 -$0.04 --
09/25/2020 Q2 -- -- -$0.06 -$0.04 -$0.02
05/07/2020 Q1 -- -- -$0.05 -$0.06 $0.01
02/05/2020 Q4 -- -- $0.08 -$0.04 $0.12
11/06/2019 Q3 -- -- -$0.04 -$0.06 $0.02
06/30/2019 Q2 -- -- -$0.09 -$0.03 -$0.06
03/31/2019 Q1 -- -- -$0.04 -$0.05 $0.00
12/31/2018 Q4 -- -- -$0.06 -- --
09/30/2018 Q3 -- -- -$0.04 -- --
08/27/2018 Q2 -- -- -$0.06 -- --
03/31/2018 Q1 -- -- -$0.07 -- --
12/31/2017 Q4 -- -- -$0.08 -- --
09/30/2017 Q3 -- -- -$0.06 -- --
06/30/2017 Q2 -- -- -$0.19 -- --
03/31/2017 Q1 -- -- -$0.09 -- --
12/31/2016 Q4 -- -- -$0.12 -- --
01/03/2017 Q3 -- -- $0.13 -- --
09/22/2016 Q2 -- -- -$0.32 -- --
07/01/2016 Q1 -- -- -$0.13 -- --
04/04/2016 Q4 -- -- -$0.09 -- --
11/12/2015 Q3 -- -- -$0.09 -- --
09/29/2015 Q2 -- -- -$0.17 -- --
05/29/2015 Q1 -- -- -$0.14 -- --

Paramount Gold Nevada Earnings Questions

  • How Much did Paramount Gold Nevada Generate in Revenue Last Quarter?

    Paramount Gold Nevada reported -- worth of top line sales in its most recent quarter.

  • Did Paramount Gold Nevada Beat Earnings Last Quarter?

    Paramount Gold Nevada announced earnings per share of -$0.03 which represents a miss of analyst forecast a -$0.03 per share.

  • Is Paramount Gold Nevada Profitable?

    Paramount Gold Nevada reported -$186.4K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Paramount Gold Nevada EPS Next Year?

    Paramount Gold Nevada's earnings are forecast to decrease from -$0.13 per share to -$0.14 per share next year representing a decrease of -7.69%.

  • When is Paramount Gold Nevada's Earnings Date?

    Currently, Paramount Gold Nevada has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on June 21, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Sportradar Stock Going Up?
Why Is Sportradar Stock Going Up?

Sportradar (NASDAQ:SRAD) should be on your radar for a stock…

Is Roblox Stock a Buy, Sell or Hold?
Is Roblox Stock a Buy, Sell or Hold?

Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock